Organization and Basis of Preparation

9 Months Ended

Sep. 30, 2015

Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]

Note - 1

Organization and Basis of Preparation

The information presented as of September 30, 2015 and for the three and nine month periods then ended is unaudited, but includes all adjustments (consisting only of normal recurring accruals) that the Company's management believes to be necessary for the fair presentation of results for the periods presented. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted as permitted by the Securities and Exchange Commission, although the Company believes that the disclosures included in these financial statements are adequate to make the information not misleading. The December 31, 2014 condensed consolidated balance sheet was derived from audited consolidated financial statements. These financial statements should be read in conjunction with the Company's annual report on Form 10-K for the year ended December 31, 2014.

The consolidated financial statements include the accounts of Cadus and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The Company operates in one segment: the purchase of homes and land for purposes of renovation or construction and resale. As previously reported, the Company will not maintain or seek to license its drug discovery technologies.

The results of operations for the nine month period ended September 30, 2015 is not necessarily indicative of the results to be expected for the year ending December 31, 2015.